A rare early-onset Parkinson’s disease case has revealed significant molecular changes in blood platelets, offering researchers new insights into potential biomarkers for tracking disease progression.
A new scientific study has identified molecular changes in blood platelets that could help researchers better understand the progression of Parkinson’s disease. The findings emerged from an investigation of a rare case of early-onset Parkinson’s disease involving rapid progression to dementia.
Published in the journal Movement Disorders, the research highlights how platelets, the smallest components of blood, may provide useful information about biological changes associated with the neurodegenerative disorder.
Researchers believe the findings could open new avenues for investigating blood-based biomarkers that may help monitor disease progression.
The study examined a patient in Spain diagnosed with early-onset Parkinson’s disease who experienced rapid cognitive decline and developed dementia.
The patient carried a triplication of a genomic region containing the SNCA gene, which provides instructions for producing alpha-synuclein. This protein is known to accumulate abnormally in the brains of people with Parkinson’s disease.
According to researchers from the Germans Trias i Pujol Research Institute in Spain and other institutions, the genetic alteration developed de novo, meaning it was not inherited from either parent.
The unusual nature of this case provided scientists with an opportunity to investigate how molecular changes develop as Parkinson’s disease advances.
Researchers monitored the patient over time and compared gene expression patterns at two different stages.
The first assessment was conducted when the patient was 41 years old, during the early phase of the disease. A second analysis took place at age 44, after dementia had developed.
The team examined gene expression, which helps scientists understand how actively particular genes function in biological processes. Their analysis revealed that platelets showed considerably more changes associated with disease progression than whole blood samples.
This suggests that platelets could offer a more sensitive source of molecular information for distinguishing different stages of Parkinson’s disease.
The study identified several genes whose activity changed as the disease progressed.
These genes were associated with important biological functions, including:
Mitochondrial activity: Processes involved in cellular energy production.
Protein synthesis: Biological mechanisms responsible for producing proteins.
Inflammation regulation: Processes that help control inflammatory responses in the body.
The researchers said these molecular differences provide additional information about the biological mechanisms that may contribute to Parkinson’s disease progression.
First author Susanna Jiménez-Román, a predoctoral researcher at the Germans Trias i Pujol Research Institute, explained that the rare case allowed the team to observe how molecular signals changed over time.
She highlighted that platelets demonstrated more noticeable changes than whole blood, suggesting their potential value in research into accessible biomarkers.
To determine whether similar molecular patterns could be found in other patients, researchers conducted an additional analysis involving an independent group.
This group included 15 patients with early-onset sporadic Parkinson’s disease and 18 healthy individuals.
The objective was to identify whether the molecular changes observed in the rare genetic case were also present in patients without the same genetic alteration.
The analysis found differences in platelet gene expression that overlapped with some of the findings from the original patient. These included reduced expression of an SNCA RNA variant and two genes associated with protein synthesis.
However, researchers did not observe significant differences in whole blood for the specific genes examined.
The similarities between the rare genetic case and patients with sporadic early-onset Parkinson’s disease could provide important clues about the disorder.
According to the research team, the overlapping molecular changes suggest that certain biological processes may be shared across different forms of Parkinson’s disease.
Jiménez-Román noted that studying unusual genetic cases can help scientists identify molecular mechanisms that may also be relevant to other patients.
The findings could therefore support further investigations into platelet-based biomarkers and their potential role in understanding how Parkinson’s disease develops and progresses.
Conclusion
The study highlights the potential importance of blood platelets in investigating Parkinson’s disease progression. By identifying molecular changes in platelets across different disease stages, researchers have discovered promising leads for future biomarker research. However, larger studies will be required to establish whether these changes can reliably monitor disease progression or support clinical applications.